6-Hydroxy Bexarotene is a synthetic retinoid derivative and a major active metabolite of Bexarotene, a selective retinoid X receptor (RXR) agonist. This compound exhibits enhanced solubility and metabolic stability compared to its parent molecule, making it a valuable intermediate in pharmaceutical research. Its hydroxyl group at the 6-position improves pharmacokinetic properties, facilitating better bioavailability and tissue penetration. 6-Hydroxy Bexarotene retains the RXR-binding affinity of Bexarotene, enabling its use in studies targeting cancer, dermatological conditions, and metabolic disorders. Its well-characterized structure and reactivity also make it suitable for derivatization in drug development. The compound is typically utilized in preclinical research for investigating retinoid-mediated pathways.